-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NTM-006
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry NTM-006 Drug Details JNJ-10450232 is under development for the treatment of postoperative dental pain...
-
Product Insights
Net Present Value Model: Amikacin
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Amikacin Drug Details Amikacin is under...
-
Product Insights
Net Present Value Model: RHB-204
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model RHB-204 Drug Details RHB-204 is under...
-
Product Insights
Net Present Value Model: Epetraborole
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Epetraborole Drug Details Epetraborole is under...
-
Product Insights
Net Present Value Model: Molgradex
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Molgradex Drug Details Molgramostim (Molgradex) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ketorolac tromethamine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ketorolac tromethamine Drug Details Ketorolac tromethamine (NTM-001) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RHB-204
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RHB-204 Drug Details RHB-204 is under development for the treatment of pulmonary non-tuberculous mycobacteria...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pravibismane
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pravibismane Drug Details Pravibismane (MBN-101) is under development for the treatment and prophylaxis of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – amikacin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry amikacin Drug Details Amikacin is under development for the treatment of Mycobacterium avium infections...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – molgramostim
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry molgramostim Drug Details Molgramostim (Molgradex) is under development for the treatment of autoimmune pulmonary...